It is possible to detect and treat dormant breast cancer cells, researchers at the University of Pennsylvania's Perelman School of Medicine and the Abramson Cancer Center found.
Oncology
A recent study reduced the risk of disease progression or death by 55% in bladder cancer patients with a new combination of drugs, CNN reported Oct. 22.
A study from Boston-based Mass General Cancer Center found carcinogens can increase cancer cells' susceptibility to immune attack.
Rochester, Minn.-based Mayo Clinic has entered into a multiyear partnership with U.K.-based company Oxford Nanopore to explore genetic predispositions to cancer.
New York City-based Memorial Sloan Kettering Cancer Center is partnering with AstraZeneca and Sophia Genetics to bring its proprietary liquid biopsy and solid tumor cancer tests to a global market, according to an Oct. 18 news release.
Advertisement
Here are nine systems and organizations developing artificial intelligence models to find and treat cancer faster:
Julie Gralow, MD, was named Woman Oncologist of the Year by Women Leaders in Oncology.
U.S. News & World Report evaluated 899 hospitals across the country and ranked them for treating leukemia, lymphoma, melanoma, breast, kidney, colon, prostate, pancreatic, head and neck, orthopedic, uterine and ovarian cancers.
Even though a majority of breast cancer cases are diagnosed without a lump that can be detected, less than half recognize other symptoms often associated with it, according to new research from the Ohio State University Comprehensive Cancer Center.
Mass General Brigham President and CEO Anne Klibanski, MD, shared a muted reaction to longtime affiliate Dana-Farber Cancer Institute's decision to partner with another Boston health system for cancer care in a recent op-ed with the Boston Globe.